Molecular Mechanisms of microRNA and miRISC turnover

microRNA 和 miRISC 更新的分子机制

基本信息

项目摘要

 DESCRIPTION (provided by applicant): MicroRNAs are a class of endogenous small RNAs that are bound by Argonaute proteins to form the microRNA-Induced Silencing Complex (miRISC). MicroRNAs in miRISC negatively regulate complementary protein-coding genes to control many aspects of normal development. The biogenesis of microRNAs and miRISC is extensively studied, but comparatively little is understood about their turnover. Untemplated nucleotide additions at the 3' end of microRNAs are correlated with destabilization, but their functional role remains unclear. The objective of this work is to elucidate the mechanisms of microRNA and miRISC turnover, and to examine the role of 3' nucleotide additions in these processes. First, I will examine the function of candidate genes in 3' nucleotide additions and microRNA decay in the context of acute inactivation of microRNA biogenesis. Second, I will establish a system to measure the turnover of endogenously-expressed Argonaute, and use this system to assess the extent to which microRNA and miRISC turnover are coupled or independent. Third, I will conduct forward genetic screens to identify factors that impact the rate of microRNA turnover. Together, these studies will deepen our understanding of how the abundance of microRNAs and miRISC is regulated, and open up multiple new directions of research. I am uniquely qualified to conduct this research, having studied different aspects of microRNA regulation and biology throughout my graduate and postdoctoral training. In Victor Ambros's laboratory, I have used the C. elegans model system to discover a novel mechanism of post-transcriptional regulation of microRNA activity. In the proposed work, I will apply similar techniques to dissecting microRNA and miRISC turnover, while also taking advantage of the unique focus on RNA biology at the University of Massachusetts Medical School to expand my skill set through collaboration with my advisory committee. My short term career goals are to learn new techniques in biochemistry and cell biology through formal coursework and practical training, and to carry out the proposed research while transitioning to an independent position. My long term goal is to build a multi-faceted research program on the foundation of these projects in a tenure-track position at an academic institution.
 描述(由适用提供):microRNA是一类由Argonaute蛋白约束以形成microRNA诱导的沉默复合物(Mirisc)的内源性小RNA。 Mirisc中的microRNA负调节完整的蛋白质编码基因,以控制正常发育的许多方面。 MicroRNA和Mirisc的生物发生是广泛研究的,但对其周转率相对较少。 MicroRNA 3'末端的未核苷酸添加与破坏稳定相关,但其功能作用尚不清楚。这项工作的目的是阐明MicroRNA和Miriscewrive的机制,并检查3'核苷酸在这些过程中的作用。首先,我将检查候选基因在3'核苷酸添加和microRNA衰减中的功能,在急性失活的microRNA生物发生情况下。其次,我将建立一个系统来衡量内源表达的Argonaute的营业额,并使用该系统来评估microRNA和Mirisce Cretplover耦合或独立的程度。第三,我将进行远期遗传筛选,以确定影响速率的因素 microRNA营业额。这些研究共同加深了我们对如何调节MicroRNA和Mirisc的丰度的理解,并打开了多个新的研究方向。在整个研究生和博士后培训中,我研究了MicroRNA调节和生物学的不同方面,因此我具有独特的资格进行这项研究。在维克多·安布罗斯(Victor Ambros)的实验室中,我使用了秀丽隐杆线虫模型系统来发现microRNA活性转录后调节的新机制。在拟议的工作中,我将应用类似的 剖析MicroRNA和Mirisc流动的技术,同时还利用了马萨诸塞大学医学院对RNA生物学的独特关注,通过与我的咨询委员会的合作来扩大我的技能。我的短期职业目标是通过正式的课程和实践培训来学习生物化学和细胞生物学的新技术,并在过渡到独立职位的同时进行拟议的研究。我的长期目标是在学术机构的终身制位置建立一项关于这些项目基础的多面研究计划。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Katherine McJunkin其他文献

Katherine McJunkin的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Katherine McJunkin', 18)}}的其他基金

Genetic analysis of post-transcriptional modulators of microRNAs in C. elegans
线虫 microRNA 转录后调节剂的遗传分析
  • 批准号:
    8264574
  • 财政年份:
    2011
  • 资助金额:
    $ 7.33万
  • 项目类别:
Genetic analysis of post-transcriptional modulators of microRNAs in C. elegans
线虫 microRNA 转录后调节剂的遗传分析
  • 批准号:
    8127532
  • 财政年份:
    2011
  • 资助金额:
    $ 7.33万
  • 项目类别:
Genetic analysis of post-transcriptional modulators of microRNAs in C. elegans
线虫 microRNA 转录后调节剂的遗传分析
  • 批准号:
    8438431
  • 财政年份:
    2011
  • 资助金额:
    $ 7.33万
  • 项目类别:
Biological functions and post-transcriptional regulation of microRNAs
microRNA的生物学功能和转录后调控
  • 批准号:
    10697854
  • 财政年份:
  • 资助金额:
    $ 7.33万
  • 项目类别:
Biological functions and post-transcriptional regulation of microRNAs
microRNA的生物学功能和转录后调控
  • 批准号:
    10255255
  • 财政年份:
  • 资助金额:
    $ 7.33万
  • 项目类别:
Biological functions and post-transcriptional regulation of microRNAs
microRNA的生物学功能和转录后调控
  • 批准号:
    10008705
  • 财政年份:
  • 资助金额:
    $ 7.33万
  • 项目类别:
Biological functions and post-transcriptional regulation of microRNAs
microRNA的生物学功能和转录后调控
  • 批准号:
    9554532
  • 财政年份:
  • 资助金额:
    $ 7.33万
  • 项目类别:
Biological functions and post-transcriptional regulation of microRNAs
microRNA的生物学功能和转录后调控
  • 批准号:
    10919521
  • 财政年份:
  • 资助金额:
    $ 7.33万
  • 项目类别:

相似海外基金

Activity-Dependent Regulation of CaMKII and Synaptic Plasticity
CaMKII 和突触可塑性的活动依赖性调节
  • 批准号:
    10817516
  • 财政年份:
    2023
  • 资助金额:
    $ 7.33万
  • 项目类别:
Glia Exclusive Gene Therapy
胶质细胞独家基因疗法
  • 批准号:
    10739502
  • 财政年份:
    2023
  • 资助金额:
    $ 7.33万
  • 项目类别:
Pathogenesis of thrombotic microangiopathies
血栓性微血管病的发病机制
  • 批准号:
    10608740
  • 财政年份:
    2023
  • 资助金额:
    $ 7.33万
  • 项目类别:
R21 MPI microRNA directed therapy for treating early stage pancreatic cancer
R21 MPI microRNA 定向疗法治疗早期胰腺癌
  • 批准号:
    10577609
  • 财政年份:
    2023
  • 资助金额:
    $ 7.33万
  • 项目类别:
IL-17A mRNA-targeted oligonucleotide therapeutics in Idiopathic Pulmonary Fibrosis (IPF)
IL-17A mRNA 靶向寡核苷酸治疗特发性肺纤维化 (IPF)
  • 批准号:
    10761365
  • 财政年份:
    2023
  • 资助金额:
    $ 7.33万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了